comparemela.com

Eyepoint Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ArriVent Appoints Kristine Peterson to its Board of Directors

NEWTON SQUARE, Pa., April 22, 2024 (GLOBE NEWSWIRE) ArriVent BioPharma, Inc., a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the appointment of

Eyepoint pharmaBristol myers squibbKristine petersonBing yaoImmunogen incArrivent biopharma incParatek pharmaceuticalsUniversity of illinois at urbana champaignImmunocore incEnanta pharmaceuticalsValeritas incOperations for biovail corporationAmarin corporationExchange commission onExchange commissionCompany group

EyePoint Pharmaceuticals to Report Third Quarter 2023

WATERTOWN, Mass., Oct. 25, 2023 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing.

United statesChristina tartagliaAmy phillipsEyepoint pharmaceuticals nasdaqEyepoint pharmaceuticalsEyepoint pharmaceuticals incGreen room communicationsPoint pharmaceuticalsNasdaq eyptEyepoint pharmaceuticalsEyepoint pharma

EyePoint Pharmaceuticals Announces Participation at

WATERTOWN, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and.

United statesAmy phillipsChristina tartagliaEyepoint pharmaceuticals nasdaqEyepoint pharmaceuticals incEyepoint pharmaceuticalsGreen room communicationsPanel discussionPoint pharmaceuticalsAnnual biopharmaAnnual global investmentFitzgerald global healthcareNasdaq eyptEyepoint pharmaceuticalsEyepoint pharma

Week In Review: invoX, A Sino Biopharm Company, To Pay $161 Million To Acquire F-Star

invoX Pharma, a Sino Biopharm subsidiary, will pay $161 million to acquire F-Star, a Cambridge, UK clinical-stage company developing bispecific drugs for immunotherapies.

United kingdomUnited statesSino biopharmaEyepoint pharmaSino biopharmSihuan pharmaAbogen biosciencesXuanzhu biopharmAsia pharmaGenor biopharmaReistone biopharmaJiangsu hengrui pharmaWensheng weiAxbio anxuyuanCompany newsIndustry fund

EyePoint Pharmaceuticals Appoints Jay S Duker, M D as

WATERTOWN, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and.

United statesHarvard universityTufts medical centerAmy phillipsHemera biosciencesJays dukerChristina tartagliaGoran andoDepartment of ophthalmology at tufts medical centerEngland eye centerJefferson medical college of thomas universityExchange commissionEyepoint pharmaceuticals nasdaqTufts university school of medicineGreen room communicationsEyepoint pharmaceuticals

vimarsana © 2020. All Rights Reserved.